Identification of spirodioxolane nsP2 helicase inhibitors with antialphaviral activity
Authors:
- Hans J. OhHOHans J. Oh
- John D. SearsJSJohn D. Sears
- Bose Muthu RamalingamBRBose Muthu Ramalingam
- Rahman Shah Zaib SaleemRSRahman Shah Zaib Saleem
- Zachary W. Davis-GilbertZDZachary W. Davis-Gilbert
- Mohammed Anwar HossainMHMohammed Anwar Hossain
- Stella R. MoormanSMStella R. Moorman
- Durbadal OhjaDODurbadal Ohja
- Sabian A. MartinezSMSabian A. Martinez
- Jane E. BurdickJBJane E. Burdick
- Rafael M. CouñagoRCRafael M. Couñago
- Nathaniel J. MoormanNMNathaniel J. Moorman
Open Access
- 31 October 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 17 (1) , 452-476
Abstract
Spirodioxolanes were identified as a new series of direct-acting nsP2 helicase inhibitors with activity against alphaviruses. Analogs such as 6b maintained activity against viral mutants with resistance to first-generation nsP2 helicase inhibitors.Keywords
All Related Versions
Funding Information
- Center for Scientific Review (1U19AI171292-01)
- Center for Scientific Review (S10OD032476)
This publication has 14 references indexed in Scilit:
- Enantioselective Chemical Probe for Chikungunya nsP2 Helicase with Antialphaviral ActivityACS Infectious Diseases, 2025
- Identification of Direct-Acting nsP2 Helicase Inhibitors with Antialphaviral ActivityJournal of Medicinal Chemistry, 2025
- Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti‐Alphavirus TherapiesReviews in Medical Virology, 2025
- Structural Chemistry of Helicase InhibitionJournal of Medicinal Chemistry, 2025
- Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approachProceedings of the National Academy of Sciences, 2024
- Inhibitors of the Structural and Nonstructural Proteins of AlphavirusesACS Infectious Diseases, 2024
- Challenges for the Discovery of Non‐Covalent WRN Helicase InhibitorsChemMedChem, 2024
- Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and BeyondChemical Reviews, 2021
- Understanding the alphaviruses: Recent research on important emerging pathogens and progress towards their controlAntiviral Research, 2010
- Uses and production of chiral 3-hydroxy-γ-butyrolactones and structurally related chemicalsApplied Microbiology and Biotechnology, 2009